Danaher Corp. will expand its in vitro diagnostics offerings through its acquisition of urinalysis device maker IRIS International Inc.for $338 million under a definitive agreement announced Sept. 17.
IRIS’ in vitro diagnostic (IVD) offerings are used to analyze the chemistry and morphology of cells and sediments in body fluids – with urinalysis as its primary focus – and the firm is the leading